Compugen Ltd.

CGEN

Healthcare Biotechnology

Compugen Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $72.8 million, up 161.1% from fiscal 2024.

Revenue
+107.0%
EPS
+12.5%
Free cash flow
−155.4%

Quarter to June 2026, against a year earlier

1.96 0.04 +2.08%
Market cap
$185.7M
P/E
5.2×
Fwd P/E
n/m
Dividend yield
—
F-score
7/9
ROIC
0.00%
Net debt / EBITDA
−4.7×
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
2 — — — — — 3 4 5 7
P/E ratio
0.00 — 0.00 — 0.00 0.00 0.00 0.00 0.00 4.14
P/S ratio
364.28 — 6.72 — 48.68 22.92 3.96 11.31 4.92 1.96
Altman Z-Score
14.57 — (4.47) — 27.57 4.19 (4.74) (2.81) (3.87) (0.37)
P/FCF ratio
0.00 — 0.00 — 0.00 0.00 0.00 0.00 2.16 1.41
Altman Z″-Score (non-manufacturers)
(1.40) — (16.25) — 1.74 (2.53) (8.19) (7.46) (8.87) (0.84)
P/Operating CF
(10.13) — (4.68) — (37.64) (14.14) (2.40) (6.84) 2.76 4.52
Beneish M-Score
(5.65) — — — — (1.69) (2.68) 5.58 (5.68) (1.59)
P/B ratio
4.08 — 3.22 — 8.05 3.39 0.79 2.67 2.49 1.39
EV/Sales
277.86 — 4.16 — 42.39 15.46 (1.44) 8.01 1.21 (0.04)
EV/EBITDA
0.00 — 0.00 — 0.00 0.00 0.52 0.00 0.00 0.00
EV/FCF
(3.32) — (1.10) — (10.00) (3.17) 0.24 (1.13) 0.53 (0.03)
Current Ratio
13.22 5.03 4.66 6.60 12.27 7.21 7.23 4.36 5.26 6.56
Net Debt/EBITDA
1.98 0.85 2.09 1.57 4.04 3.40 2.40 3.99 6.46 (4.65)
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(41.07%) (79.87%) (67.93%) (72.35%) (37.57%) (30.20%) (36.55%) (26.19%) (23.63%) 44.84%
ROA
(36.97%) (67.46%) (49.17%) (51.12%) (30.92%) (25.29%) (29.77%) (17.40%) (12.04%) 26.03%
ROIC
(1,022.31%) 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% (55.97%) 0.00% 0.00%
Return on Tangible Assets
(49.30%) (125.09%) (56.55%) (67.47%) (24.69%) (31.73%) (44.49%) (20.95%) (16.42%) 28.02%
Average Days of Receivables
591.07 0.00 18.52 0.00 850.09 332.15 117.63 693.03 35.92 11.95
Earnings Yield
(12.16%) — (18.34%) — (3.06%) (9.30%) (56.34%) (11.00%) (10.18%) 24.18%
Free Cash Flow Yield
(22.97%) — (56.50%) — (8.71%) (21.27%) (150.38%) (62.89%) 46.22% 71.14%
Free Cash Flow per Share
(0.44) (0.61) (0.24) (0.43) (0.36) (0.27) (0.40) (0.41) 0.55 0.34
Book value per Share
1.25 0.57 0.67 0.60 1.51 1.27 0.90 0.75 0.61 1.10
Free Cash Flow
(22.42) (31.04) (13.45) (27.66) (28.44) (23.04) (34.59) (36.06) 49.49 31.33
EV/EBIT
0.00 — 0.00 — 0.00 0.00 0.63 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates